Abingdon, United Kingdom

Karen Parrish

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Karen Parrish: Innovator in Pharmaceutical Research

Introduction

Karen Parrish is a distinguished inventor based in Abingdon, GB. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for various diseases. With a total of 2 patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Among her latest patents is a groundbreaking invention related to Heteroaryl SYK inhibitors. This invention focuses on new substituted heteroaryls of a specific formula, which are designed to treat diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis, and rheumatoid arthritis. The compounds developed by Parrish are aimed at providing effective therapeutic options for patients suffering from these conditions.

Career Highlights

Karen Parrish is currently employed at Boehringer Ingelheim International GmbH, where she continues to advance her research and development efforts. Her work at this esteemed company has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical innovation.

Collaborations

Throughout her career, Parrish has worked alongside notable colleagues such as Georg Dahmann and Matthias Hoffmann. These collaborations have played a crucial role in the success of her projects and the advancement of her research.

Conclusion

Karen Parrish is a remarkable inventor whose work in pharmaceutical research is paving the way for new treatments for various diseases. Her innovative spirit and dedication to improving healthcare continue to inspire those in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…